New study reveals pandemic-specific depression and anxiety among individuals with multiple sclerosis

Widely used nausea drugs linked to heightened risk of stroke
23 March 2022
COVID comeback seen in parts of US as funding runs dry
24 March 2022

New study reveals pandemic-specific depression and anxiety among individuals with multiple sclerosis

Kessler Foundation researchers published results of a survey of the emotional outcomes of individuals with multiple sclerosis (MS) during the COVID-19 pandemic. Comparison of data collected during the pandemic with pre-pandemic data for the study sample suggests the occurrence of pandemic-specific depression and anxiety. Their article, “Surviving a global pandemic: The experience of depression, anxiety, and loneliness among individuals with multiple sclerosis,” was published online in Multiple Sclerosis and Related Disorders on January 14, 2022. The authors are Lauren Strober, Ph.D., Erica Weber, Ph.D., Anthony Lequerica, Ph.D., and Nancy Chiaravalloti, Ph.D., of Kessler Foundation.

Comments are closed.